Genpact Limited (G) — Fair Value Analysis

Base-case fair value (P50): $36.98 · Current price: $32.62 · Verdict: Fairly Valued

The Verdict on G

GENPACT LTD (G) is currently assessed as Fairly Valued according to our Monte Carlo simulations. At a $32.62, the stock trades below our median fair value (P50) of $36.98, indicating a potential +13.4% upside based on thousands of simulated forward scenarios. This analysis suggests that G's current valuation aligns closely with its intrinsic worth, considering its operational and financial health which registers as an average quality tier relative to its sector. While there is a slight buffer to the P50, the overall picture suggests an efficient market pricing for G at this juncture, with its current valuation reflecting a balanced risk-reward profile without significant disparity from its derived fair value.

How G stacks up against peers

GENPACT LTD’s average quality tier in its sector is a key factor influencing its fair value determination. This positioning implies that G exhibits a moderate level of operational and financial strength when compared to its industry counterparts, neither significantly outperforming nor underperforming the broader competitive landscape. Our Monte Carlo simulations, which incorporate these fundamental health indicators, arrive at a median fair value of $36.98. The current trading price of $32.62 offers a +13.4% gap, suggesting that while G is not a screaming bargain, its current valuation is robust given its competitive standing. Investors should view this average quality tier as a stable baseline in evaluating G’s future potential.

What this means for investors

For investors considering GENPACT LTD (G), the verdict of Fairly Valued implies that the stock's $32.62 largely reflects its intrinsic value, as modeled by our sophisticated Monte Carlo approach. The identified +13.4% to the $36.98 median fair value presents a modest buffer, suggesting that significant mispricing is unlikely at current levels. Given G's average quality tier, its valuation reflects a balanced outlook without extreme catalysts or concerns. To fully understand the range of potential outcomes, including various upside and downside scenarios that inform our FairCurve analysis, sign up for a free FairCurve account to see the full bear/bull distribution and track G's fair value as new fundamentals are released.

Frequently Asked Questions

Is G overvalued or undervalued right now?

Based on our Monte Carlo simulations, GENPACT LTD (G) is assessed as Fairly Valued. Its current price of $32.62 trades below our median fair value (P50) of $36.98, indicating a potential +13.4%.

What is the bear case and bull case for G?

The full Monte Carlo distribution, including our bear (P10) and bull (P90) target prices, as well as the precise probability of upside from current levels, is available exclusively to users with a free FairCurve account.

How does FairCurve calculate G's fair value?

FairCurve calculates G's fair value using sophisticated Monte Carlo simulations, modeling thousands of forward-looking scenarios to determine a robust intrinsic value range.

How can I track G's fair value as it changes?

You can add G to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or significant fundamental data are released.